000

SHINIL PHARM

No trades
See on Supercharts
Market capitalization
‪81.66 B‬KRW
‪13.64 B‬KRW
‪89.14 B‬KRW
‪6.89 M‬
Beta (1Y)
0.80

About SHINIL PHARM

CEO
Jae-Hyun Hong
Headquarters
Chungju-si
Founded
1971
ISIN
KR7012790002
FIGI
BBG000BB7175
Sinil Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. It operates through the following business divisions: Drug, Health Functional Food, Cosmetics, Real Estate, and Quasi-Drugs. The company was founded by Sung-So Hong in November 1971 and is headquartered in Chungju-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 012790 is 7080 KRW — it has increased by 0.28% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SHINIL PHARM stocks are traded under the ticker 012790.
012790 stock is 0.99% volatile and has beta coefficient of 0.80. Check out the list of the most volatile stocks — is SHINIL PHARM there?
Yes, you can track SHINIL PHARM financials in yearly and quarterly reports right on TradingView.
012790 stock has risen by 3.51% compared to the previous week, the month change is a 4.19% fall, over the last year SHINIL PHARM has showed a 10.72% decrease.
012790 net income for the last quarter is ‪4.68 B‬ KRW, while the quarter before that showed ‪3.47 B‬ KRW of net income which accounts for 34.88% change. Track more SHINIL PHARM financial stats to get the full picture.
Today SHINIL PHARM has the market capitalization of ‪81.61 B‬, it has increased by 2.19% over the last week.
Yes, 012790 dividends are paid annually. The last dividend per share was 170.00 KRW. As of today, Dividend Yield (TTM)% is 2.41%. Tracking SHINIL PHARM dividends might help you take more informed decisions.
SHINIL PHARM dividend yield was 2.20% in 2023, and payout ratio reached 14.41%. The year before the numbers were 1.13% and 9.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 012790 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHINIL PHARM stock right from TradingView charts — choose your broker and connect to your account.
012790 reached its all-time high on Jul 23, 2020 with the price of 52660 KRW, and its all-time low was 730 KRW and was reached on Aug 3, 2004.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHINIL PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHINIL PHARM stock shows the sell signal. See more of SHINIL PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHINIL PHARM EBITDA is ‪18.79 B‬ KRW, and current EBITDA margin is 21.09%. See more stats in SHINIL PHARM financial statements.